UPDATED Apr 18, 2023
Online and catalog retail companies worldwide.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
719Shandong Xinhua Pharmaceutical | HK$6.37 | 0.8% | 37.9% | HK$14.4b | n/a | PE9.2x | n/a | 3.6% | ||
3613Beijing Tong Ren Tang Chinese Medicine | HK$15.10 | 5.9% | 41.7% | HK$12.6b | HK$15.56 | PE19.6x | E11.3% | 2.2% | ||
3933United Laboratories International Holdings | HK$5.80 | 1.8% | 46.5% | HK$10.5b | HK$5.85 | PE5.9x | E-2.2% | 4.9% | ||
2315Biocytogen Pharmaceuticals (Beijing) | HK$24.65 | -1.4% | n/a | HK$9.8b | HK$33.69 | PS16.2x | E71.5% | n/a | ||
1349Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd | HK$3.30 | 0.6% | -1.8% | HK$9.7b | n/a | PE21.6x | n/a | 2.4% | ||
1666Tong Ren Tang Technologies | HK$7.54 | 4.7% | 23.6% | HK$9.7b | HK$7.56 | PE14.5x | E6.7% | 2.4% | ||
2696Shanghai Henlius Biotech | HK$16.90 | 27.1% | -11.1% | HK$9.2b | HK$35.45 | PS2.5x | E94.4% | n/a | ||
6955Shandong Boan Biotechnology | HK$17.84 | -5.5% | n/a | HK$9.1b | HK$16.70 | PS15.5x | S54.2% | n/a | ||
2157Lepu Biopharma | HK$5.43 | -1.6% | -16.5% | HK$9.0b | HK$6.50 | PS508.2x | S81.4% | n/a | ||
2171CARsgen Therapeutics Holdings | HK$13.88 | -2.1% | 10.2% | HK$8.0b | HK$23.13 | PB2.8x | E3.2% | n/a | ||
460Sihuan Pharmaceutical Holdings Group | HK$0.84 | -1.2% | -38.2% | HK$7.8b | n/a | PS3.2x | n/a | 8.8% | ||
775CK Life Sciences Int'l. (Holdings) | HK$0.80 | 1.3% | 27.0% | HK$7.7b | n/a | PE58.3x | n/a | 1.0% | ||
6600SciClone Pharmaceuticals (Holdings) | HK$12.04 | 8.7% | 49.0% | HK$7.3b | HK$12.26 | PE7.5x | E-2.5% | 3.2% | ||
2179Jiangsu Recbio Technology | HK$14.88 | -7.6% | -40.0% | HK$7.2b | HK$33.98 | PB3.8x | E23.5% | n/a | ||
6855Ascentage Pharma Group International | HK$24.80 | -0.4% | 73.4% | HK$7.0b | HK$31.88 | PS29.2x | E33.1% | n/a | ||
1558YiChang HEC ChangJiang Pharmaceutical | HK$7.45 | -4.9% | 53.6% | HK$6.6b | HK$10.77 | PE75.2x | E77.3% | 0% | ||
2877China Shineway Pharmaceutical Group | HK$8.60 | -0.2% | 39.6% | HK$6.5b | HK$10.81 | PE7.9x | E8.4% | 5.5% | ||
1167Jacobio Pharmaceuticals Group | HK$7.85 | 2.1% | 7.4% | HK$6.2b | HK$9.85 | PS57.1x | E-6.7% | n/a | ||
1477Ocumension Therapeutics | HK$9.00 | -7.5% | 1.7% | HK$6.2b | HK$15.25 | PS34.2x | E6.2% | n/a | ||
1521Frontage Holdings | HK$2.56 | 2.8% | 9.9% | HK$5.2b | HK$3.60 | PE25.8x | E27.6% | n/a | ||
2257Sirnaomics | HK$58.70 | -3.7% | -30.6% | HK$5.2b | HK$80.51 | PS25468.7x | E11.1% | n/a | ||
2616CStone Pharmaceuticals | HK$3.71 | -4.6% | n/a | HK$4.7b | HK$7.27 | PS9.8x | E48.1% | n/a | ||
1952Everest Medicines | HK$15.06 | -5.4% | -31.1% | HK$4.6b | HK$24.14 | PS316.7x | E20.1% | n/a | ||
1681Consun Pharmaceutical Group | HK$4.91 | 0% | 11.3% | HK$3.9b | HK$5.79 | PE5x | E10.9% | 6.0% |